Do benefits outweigh risk of mind-altering drug use by healthy individuals?

April 20, 2017, Wiley

Psychoactive substances are becoming increasingly available to individuals for treating mental health disorders and enhancing cognition, as well as for purposes of creativity, inner exploration, and enjoyment. A new review published in the British Journal of Pharmacology looks at how these products may provide benefits, as well as how their ease of accessibility is raising a variety of concerns.

Barbara Sahakian, FMedSci DSc, and her colleagues at the University of Cambridge in the United Kingdom address these issues by summarizing studies that have looked into the effects of in healthy individuals and have explored the characteristics and motivations of users. The review also considers safety, ethical, and regulatory concerns related to the increasing use of these substances, which include stimulant-type drugs (e.g., synthetic cathinones, piperazines, phenethylamines), hallucinogens (e.g., tryptamines), cannabis-like compounds, dissociative drugs (e.g., arylcyclohexylamines, nitrous oxide), sedatives/hypnotics, and opioids.

Various studies highlighted in the review have demonstrated that cognitive-enhancing drugs can indeed moderately enhance cognitive performance in healthy individuals and that the stimulant modafinil may be beneficial to certain populations such as sleep-deprived doctors and shift workers. Therefore, the advantages of these drugs in healthy people should be considered and researched further. It will also be important to consider the negative factors that may drive people to seek cognitive enhancement, such as stress and increasing demands in the workplace. In addition, ethical issues of coercion and fairness, safety issues, and societal values and views should not be overlooked.

"The increasing lifestyle use of by is changing society as we know it," said Prof. Sahakian. "We need to have a conversation about the reasons people to choose to enhance and ensure that enhancement is not seen as a replacement to the health and wellbeing of the population."

In terms of safety, concerns include use in children and adolescents whose brains are still in development. Also, using the drug without consulting a medical doctor may put some individuals at risk if the drug is counter-indicated for them, for example due to or other medications they may be taking that may result in drug- interactions. In addition, there are no long-term safety and efficacy studies, and many people are purchasing these drugs over the Internet without assurances of content and quality control.

"The long-term effects on physical and mental health remain to be determined. More research is needed into these substances and the patterns of their use to better understand their acute and long-term health effects and to establish effective harm reduction strategies," said lead author Camilla d'Angelo, PhD.

Explore further: Fair play? How 'smart drugs' are making workplaces more competitive

More information: British Journal of Pharmacology (2017). DOI: 10.1111/bph.13813

Related Stories

Fair play? How 'smart drugs' are making workplaces more competitive

July 1, 2016
We live in an increasingly competitive world where we are always looking to gain an advantage over our rivals, sometimes even our own colleagues. In some cases, it can push people to extreme, unethical and illegitimate methods ...

Synthetic drug use rapidly rising in Europe, report finds

May 28, 2013
New synthetic psychoactive substances are making their way into Europe where the Internet is becoming a big challenge in the fight against illicit drugs, the continent's drug agency warned Tuesday.

Study to look at the impact of legal alternatives to illegal drugs

November 14, 2012
The use of legal substances that mimic the effects of illegal drugs appears to be on the rise in Australia, yet little is known about their long-term impact on users.

Record seizure of smart drugs including one untested in humans shows growing market

November 3, 2014
People desire to enhance themselves in all sorts of ways: physically through cosmetic surgery; sexually through Viagra; and through using cognitive enhancing, or smart, drugs to perform better at school or work. In such a ...

Researchers hope to forecast novel psychoactive substance use by the public

May 14, 2015
The use of novel psychoactive substances – synthetic compounds with stimulant or hallucinogenic effects – is on the rise. The diversity and breadth of these substances has led policymakers, law enforcement officers, ...

Researchers document self-reported use of new synthetic drugs by teens and young adults

September 15, 2015
In recent years, there has been an increase in emergence and use of a variety of new drugs, so-called "novel psychoactive substances" (NPS) in the US and worldwide. However, there is little published survey data estimating ...

Recommended for you

Warning labels on alcohol containers highly deficient, new research shows

May 21, 2018
Current health warning labels on alcohol beverage containers in New Zealand are highly deficient, new research from the University of Otago, Wellington shows.

Serving smaller alcoholic drinks could reduce the U.K.'s alcohol consumption

May 14, 2018
New research published in Addiction, conducted by researchers from the Universities of Liverpool and Sheffield, highlights the potential benefits of reducing the standard serving size of alcoholic beverages.

Anti-alcoholism drug shows promise in animal models

May 3, 2018
Scientists at The University of Texas at Austin have successfully tested in animals a drug that, they say, may one day help block the withdrawal symptoms and cravings that incessantly coax people with alcoholism to drink. ...

FDA-approved drugs to treat diabetes and obesity may reduce cocaine relapse and help addicted people break the habit

April 28, 2018
Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances. Moreover, relapse rates hover between 40 and 60 percent, similar to rates ...

Buprenorphine may be safer than methadone if treatment duration is longer, study suggests

April 20, 2018
The less commonly prescribed opioid substitute buprenorphine may be safer than methadone for problem opioid users, especially if used during the first month of treatment, according to a study which includes University of ...

Binge-eating mice reveal obesity clues

April 9, 2018
Obesity is a growing issue in many countries, accelerated by easy access to calorie-dense foods that are pleasurable to eat (known as an 'obesogenic environment'). But while it's clear that eating too much leads to weight ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.